Expression of human estrogen receptor-α and -β, progesterone receptor, and androgen receptor mRNA in normal and malignant ovarian epithelial cells
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Our understanding of the roles played by sex hormones in ovarian carcinogenesis has been limited by a lack of data concerning the mode of sex hormone action in human ovarian surface epithelial (HOSE) cells, the tissue of origin of >90% of ovarian cancers. We have compared the relative abundance of estrogen receptor (ER)α, ERβ, progesterone receptor (PR), and androgen receptor (AR) mRNA in four primary cultures of HOSE cells obtained from postmenopausal women to those found in late serous adenocarcinoma primary cell cultures and established ovarian cancer cell lines. We observed coexpression of ERα and ERβ mRNA along with AR and PR transcripts in normal HOSE cells and disruption of ERα mRNA expression as well as dramatic down-regulation of PR and AR transcript expression in most ovarian cancer cells. In contrast, levels of ERβ mRNA were unaffected by the malignant state. Additionally, a novel mutation involving a 32-bp deletion in exon 1 of ERα transcripts was detected in the SKOV3 cell line. This mutation would explain why SKOV3 was reported to be ER-positive but estrogen-insensitive. Taken together, these findings suggest that estrogens, signaling via either or both ER subtypes, may play an indispensable role in regulating normal HOSE cell functions. Therefore, loss of ERα, PR, and AR mRNA expression in HOSE cells may be responsible for neoplastic transformation in this cell type. In contrast, the roles played by ERβ in normal and malignant HOSE cells remain elusive. Finally, the coexistence of mutated ERα mRNA and normal ERβ transcripts in SKOV3 argues in favor of a dependency of ERβ action on functional ERαs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cloning of a novel receptor expressed in rat prostate and ovary.
Kuiper, G. G., Enmark, E., Pelto-Huikko, M., Nilsson, S., & Gustafsson, J. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.5925 · Cited by 4,788
Kuiper, G. G. J. M., Carlsson, B., Grandien, K., Enmark, E., Häggblad, J., Nilsson, S., & Gustafsson, J.-A. (1997) · Endocrinology · doi:10.1210/endo.138.3.4979 · Cited by 4,442
ERβ: Identification and characterization of a novel human estrogen receptor
Mosselman, S., Polman, J., & Dijkema, R. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00782-x · Cited by 2,269
Risch, H. A. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.23.1774 · Cited by 771
Role of co-activators and co-repressors in the mechanism of steroid/thyroid receptor action.
Shibata, H., Spencer, T. E., Oñate, S. A., Jenster, G. W., Tsai, M., Tsai, M., & O’Malley, B. W. (1997) · PubMed · Cited by 520
HORWITZ, K. B., KOSEKI, Y., & McGUIRE, W. L. (1978) · Endocrinology · doi:10.1210/endo-103-5-1742 · Cited by 415
Extension of the Life-Span of Human Endothelial Cells by an Interleukin-1αAntisense Oligomer
Maier, J. A. M., Voulalas, P., Roeder, D., & Maciag, T. (1990) · Science · doi:10.1126/science.2218499 · Cited by 397
Cancer Incidence in a Cohort of Infertile Woman
Modan, B., Ron, E., Lerner-Geva, L., Blumstein, T., Menczer, J., Rabinovici, J., Oelsner, G., Freedman, L., Mashiach, S., & Lunenfeld, B. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009397 · Cited by 361
Zhang, Q., Borg, Å., Wolf, D. M., Oesterreich, S., & Fuqua, S. A. W. (1997) · PubMed · Cited by 337
Estrogen Receptor-β mRNA Expression in Rat Ovary: Down-Regulation by Gonadotropins
Byers, M., Kuiper, G. G. J. M., Gustafsson, J.-A., & Park-Sarge, O.-K. (1997) · Molecular Endocrinology · doi:10.1210/mend.11.2.9887 · Cited by 304
Cited by
Ovarian Surface Epithelium: Biology, Endocrinology, and Pathology*
Auersperg, N., Wong, A. S. T., Choi, K.-C., Kang, S. K., & Leung, P. C. K. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.2.0422 · Cited by 1,046
Menopausal Hormone Replacement Therapy and Risk of Ovarian Cancer
Lacey, Jr. (2002) · JAMA · doi:10.1001/jama.288.3.334 · Cited by 606
Loss of ERβ expression as a common step in estrogen-dependent tumor progression
Bardin, A., Boulle, N., Lazennec, G., Vignon, F., & Pujol, P. (2004) · Endocrine-Related Cancer · doi:10.1677/erc.1.00800 · Cited by 417
Estrogen Receptor Mutations in Human Disease
Herynk, M. H., & Fuqua, S. A. W. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0010 · Cited by 400
Endogenous Hormones and Ovarian Cancer: Epidemiology and Current Hypotheses
Lukanova, A., & Kaaks, R. (2005) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.98.14.1 · Cited by 314
The biological role of estrogen receptors α and β in cancer
Pearce, S. T., & Jordan, V. C. (2004) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2003.09.003 · Cited by 311
Okubo, T., Yokoyama, Y., Kano, K., & Kano, I. (2001) · Food and Chemical Toxicology · doi:10.1016/s0278-6915(01)00073-4 · Cited by 286
Induction of hTERT Expression and Telomerase Activity by Estrogens in Human Ovary Epithelium Cells
Misiti, S., Nanni, S., Fontemaggi, G., Cong, Y.-S., Wen, J., Hirte, H. W., Piaggio, G., Sacchi, A., Pontecorvi, A., Bacchetti, S., et al. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.11.3764-3771.2000 · Cited by 254
Estrogen, Progesterone and Epithelial Ovarian Cancer
Ho, S.-M. (2003) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-1-73 · Cited by 254
Self-citationPark, S.-H., Cheung, L. W. T., Wong, A. S. T., & Leung, P. C. K. (2008) · Molecular Endocrinology · doi:10.1210/me.2007-0512 · Cited by 200
“This ovarian cancer cell line is ER positive but ER negative due to inactivating mutation, which renders the cells insensitive to estrogen in terms of cell proliferation and gene induction (24, 37).”
BackgroundRisk Factors for Ovarian Cancer: An Overview with Emphasis on Hormonal Factors
Salehi, F., Dunfield, L., Phillips, K. P., Krewski, D., & Vanderhyden, B. C. (2008) · Journal of Toxicology and Environmental Health, Part B · doi:10.1080/10937400701876095 · Cited by 199
“…cancers express estrogen receptors (ER), progesterone receptors (PR), and androgen receptors (AR) (Hamilton et al., 1981; Rao & Slotman, 1991; Chadha et al., 1993; Cardillo et al., 1998; Hillier et al., 1998; Pujol et al., 1998; Lau et al., 1999; Akahira et al., 2002; Lindgren et al., 2004).”
BackgroundSaunders, P. T. K., Millar, M. R., Williams, K., Macpherson, S., Harkiss, D., Anderson, R. A., Orr, B., Groome, N. P., Scobie, G., & Fraser, H. M. (2000) · Biology of Reproduction · doi:10.1095/biolreprod63.4.1098 · Cited by 175
Expression of progesterone receptor is a favorable prognostic marker in ovarian cancer
Lee, P., Rosen, D. G., Zhu, C., Silva, E. G., & Liu, J. (2005) · Gynecologic Oncology · doi:10.1016/j.ygyno.2004.11.010 · Cited by 160
Phenotypic heterogeneity of mutations in androgen receptor gene
Singh, R., Singh, L., & Thangaraj, K. (2007) · Asian Journal of Andrology · doi:10.1111/j.1745-7262.2007.00250.x · Cited by 159
Charles, N. J., Thomas, P., & Lange, C. A. (2010) · Hormones and Cancer · doi:10.1007/s12672-010-0023-9 · Cited by 86
Metadata
- Authors
- Lau, K.-M., Mok, S. C., & Ho, S.-M.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1999-05-11
- Volume
- 96
- Issue
- 10
- Pages
- 5722-5727
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1967387654
- Cited by
- 277
- References
- 36
- FWCI
- 7.09
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.